Role of S-nitrosation of cysteine residues in long-lasting inhibitory effect of nitric oxide on arterial tone

Molecular Pharmacology

Volumn 63, Issue 5, 2003, Pages 1148-1158

  Alencar, Jacicarlos L ^a,b,e   Lobysheva, Irina ^c   Geffard, Michel ^d   Sarr, Mamadou ^a   Schott, Christa ^a   Schini Kerth, Valérie B ^a   Nepveu, Françoise ^c   Stoclet, Jean Claude ^a   Muller, Bernard ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d Ecl Prat H Etudes Phys I O M   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY TONE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG HALF LIFE; DRUG INHIBITION; ELECTRON SPIN RESONANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NITROSATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; RESIDUE ANALYSIS; SPIN TRAPPING;

ANIMALS; ARTERIES; CYSTEINE; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSATION; RATS; RATS, WISTAR; S-NITROSOGLUTATHIONE; SULFHYDRYL COMPOUNDS; VASOCONSTRICTION;

EID: 0038745435     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.63.5.1148     Document Type: Article

References (47)

1. Alencar JL, Geffard M, Stoclet J-C, and Muller B (2002a) Evidence for the formation of vasoactive nitric oxide stores by S-nitrosation of cysteine residues in isolated blood vessels exposed to S-nitrosoglutathione (Abstract). Br J Pharmacol 135:173P.
2. Alencar JL, Lobysheva I, Geffard M, Sarr M, Schott C, Schini-Kerth VB, Nepveu F, Stoclet J-C, and Muller B (2002b) Protein S-nitrosation as a mechanism of formation of releasable NO stores and long lasting decrease of arterial tone (Abstract). Nitric Oxide 6:355.
3. Arnelle DR and Stamler JS (1995) NO+, NO and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 318:279-285.
4. Arnelle DR, Day BJ, and Stamler JS (1997) Diethyldithiocarbamate-induced decomposition of S-nitrosothiols. Nitric Oxide 1:56-64.
5. Boullerne AI, Petry KG, Meynard M, and Geffard M (1995) Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine. J Neuroimmunol 60:117-124.
6. Broillet MC (1999) S-nitrosylation of proteins. Cell Mol Life Sci 55:1036-1042.
7. Brunk CF, Jones KC, and James TW (1979) Assay for nanogram quantities of DNA in cellular homogenates. Anal Biochem 92:497-500.
8. Butler AR, Flitney FW, and Williams DL (1995) NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective. Trends Pharmacol Sci 16:18-22.
9. Deneke SM, Susanto I, Vogel KA, Williams CE, and Lawrence RA (1995) Mechanisms of use of extracellular glutathione by lung epithelial cells and pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 12:662-668.
10. da Silva-Santos JE and Assreuy J (1999) Long-lasting changes of rat blood pressure to vasoconstrictors and vasodilators induced by nitric oxide donor infusion: involvement of potassium channels. J Pharmacol Exp Ther 290:380-387.
11. Eu JP, Xu L, Stamler JS, and Meissner G (1999) Regulation of ryanodine receptors by reactive nitrogen species. Biochem Pharmacol 57:1079-1084.
12. Gordge MP, Hothersall JS, and Noronha-Dutra AA (1998) Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Br J Pharmacol 124:141-148.
13. Gow AJ, Chen Q, Hess DT, Day BJ, Ischiropoulos H, and Stamler JS (2002) Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J Biol Chem 277:9637-9640.
14. Gow AJ and Stamler JS (1998) Reactions between nitric oxide and haemoglobin under physiological conditions. Nature (Lond) 391:169-173.
15. Gross SS and Lane P (1999) Physiological reactions of nitric oxide and hemoglobin: a radical rethink. Proc Natl Acad Sci USA 96:9967-9969.
16. Gupte SA, Rupawalla T, Mohazzab-H KM and Wolin MS (1999) Regulation of NO-elicited pulmonary artery relaxation and guanylate cyclase activation by NADH oxidase and SOD. Am J Physiol 276:H1535-H1542.
17. Heikkila RE, Cabbat FS, and Cohen G (1976) In vivo inhibition of superoxide dismutase in mice by diethyldithiocarbamate. J Biol Chem. 251:2182-2185.
18. Hiraishi H, Terano A, Ota S, Mutoh H, Sugimoto T, Harada T, Razandi M, and Ivey KJ (1994) Protection of cultured rat gastric cells against oxidant-induced damage by exogenous glutathione. Gastroenterology 106:1199-1207.
19. Hogg N (2000) Biological chemistry and clinical potential of S-nitrosothiols. Free Radic Biol Med 28:1478-1486.
20. Hughes MN (1999) Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite. Biochim Biophys Acta 1411:263-272.
21. Jia L, Bonaventura C, Bonaventura J, and Stamler JS (1996) S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature (Lond) 380:221-226.
22. Kleschyov AL, Mollnau H, Oelze M, Meinertz T, Huang Y, Harrison DG, and Munzel T (2000a) Spin trapping of vascular nitric oxide using colloid Fe(II)-diethyldithiocarbamate. Biochem Biophys Res Commun 275:672-67.
23. Kleschyov AL, Muller B, Kéravis T, Stoeckel M-E, and Stoclet J-C (2000b) Adventitia-derived NO in rat aorta exposed to bacterial lipopolysaccharide: cell origin and functional consequences Am J Physiol. 279:H2743-H2751.
24. Lane P, Hao G, and Gross SS (2001) S-nitrosylation is emerging as a specific and fundamental posttranslational protein modification: head-to-head comparison with O-phosphorylation. Sci STKE 86:RE1.
25. Lorch SA, Foust R 3rd, Gow A, Arkovitz M, Salzman AL, Szabo C, Veyret B, Geffard M, and Ischiropoulos H (2000) Immunohistochemical localization of protein 3-nitrotyrosine and S-nitrosocysteine in a murine model of inhaled nitric oxide therapy. Pediatr Res 47:798-805.
26. + channels in photorelaxation of vascular smooth muscle. Eur J Pharmacol 347:215-221.
27. MacKenzie A and Martin W (1998) Loss of endothelium-derived nitric oxide in rabbit aorta by oxidant stress: restoration by superoxide dismutase mimetics. Br J Pharmacol 124:719-28.
28. Manukhina EB, Mashina SYu, Smirin BV, Lyamina NP, Senchikhin VN, Vanin AF and Malyshev IYu (2000) Role of nitric oxide in adaptation to hypoxia and adaptative defense. Physiol Res 49:89-97.
29. Mayer B, Pfeiffer S, Schrammel A, Koesling D, Schmidt K, and Brunner F (1998) A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione. J Biol Chem 273:3264-3270.
30. Megson IL, Greig IR, Gray GA, Webb DJ, and Butler AR (1997) Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug. Br J Pharmacol 122:1617-1624.
31. Megson IL, Holmes SA, Magid KS, Pritchard RJ, and Flitney FW (2000) Selective modifiers of glutathione biosynthesis and 'repriming' of vascular smooth muscle photorelaxation. Br J Pharmacol 130:1575-1580.
32. Megson IL, Morton S, Greig IR, Mazzei FA, Field RA, Butler AR, Caron G, Gasco A, Fruttero R, and Webb DJ (1999) N-Substituted analogues of S-nitroso-N-acetyl-D,L-penicillamine: chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries. Br J Pharmacol 126:639-648.
33. Mnaimneh S, Geffard M, Veyret B, and Vincendeau P (1997) Albumin nitrosylated by activated macrophages possesses antiparasitic effects neutralized by anti-NO-acetylated-cysteine antibodies. J Immunol 158:308-314.
34. Muller B, Kleschyov AL, Alencar JL, Vanin AF, and Stoclet J-C (2002) Nitric oxide transport and storage in the cardiovascular system. Ann NY Acad Sci 912:131-139.
35. Muller B, Kleschyov AL, and Stoclet J-C (1996) Evidence for N-acetylcysteine sensitive nitric oxide storage as non haeme dinitrosyl-iron complexes in lipopolysaccharide-treated rat aorta. Br J Pharmacol 119:1281-1285.
36. Muller B, Kleschyov AL, Malblanc S, and Stoclet J-C (1998) Nitric oxide-related cyclic GMP-independent effect of N-acetylcysteine in lipopolysaccharide treated rat aorta. Br J Pharmacol 123:1221-1229.
37. Rassaf T, Preik M, Kleinbongard P, Lauer T, Heiss C, Strauer BE, Feelisch M, and Kelm M (2002) Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest 109:1241-1248.
38. Saville B (1958) A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 83:670-672.
39. Scharfstein JS, Keaney JF, Slivka A, Welch GN, Vita JA, Stamler JS, and Loscalzo J (1994) In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Investig 94:1432-1439.
40. Sogo N, Campanella C, Webb DJ, and Megson IL (2000) S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery. Br J Pharmacol 131:1236-1244.
41. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, and Loscalzo J (1992) Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 89:7674-7677.
42. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, and Piantadosi CA (1997) Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science (Wash DC) 276:2034-2037.
43. Stamler JS, Lamas S, and Fang FC (2001) Nitrosylation. The prototypic redox-based signaling mechanism. Cell 106:675-683.
44. Stoclet JC, Troncy E, Muller B, Brua C, and Kleschyov AL (1998) Molecular mechanisms underlying the role of nitric oxide in the cardiovascular system. Exp Opin Invest Drugs 7:1769-1779.
45. Terluk MR, Da Silva-Santos JE, and Assreuy J (2000) Involvement of soluble guanylate cyclase and calcium-activated potassium channels in the long-lasting hyporesponsiveness to phenylephrine induced by nitric oxide in rat aorta. Naunyn-Schmiedeberg's Arch Pharmacol 361:477-483.
46. Tsikas D, Sandmann J, Luessen P, Savva A, Rossa S, Stichtenoth DO, and Frolich JC (2001) S-Transnitrosylation of albumin in human plasma and blood in vitro and in vivo in the rat. Biochim Biophys Acta 1546:422-434.
47. Vanin AF (1998) Dinitrosyl iron complexes and S-nitrosothiols are two possible forms for stabilization and transport of nitric oxide in biological systems. Biochemistry (Moscow) 63:782-793.